SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Trading Update

17 Jan 2024 07:00

RNS Number : 9008Z
Mission Group PLC (The)
17 January 2024
 

17th January 2024

The Mission Group plc

("MISSION" the "Company" or the "Group")

 

Trading Update

 

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, provides a trading update for the financial year ended 31 December 2023 ("FY2023").

 

TRADING

 

Trading in the final three months of 2023 was significantly improved on the previous quarter and the Group's performance for FY2023 is expected to be in line with the revised guidance issued in its update to the market on 23 October 2023 ("the Update").

 

The Group expects to report FY2023 revenue (operating income) of £87.0m representing growth of 9% on 2022, including the impact of 2023 acquisitions, and at the higher end of the guidance provided in the Update and ahead of Advertising Association expectations for 2023 of 2.6%.

 

Headline profit before tax from continuing operations, (excluding the trading loss relating to the Group's Pathfindr business, the disposal of which was announced on 5 January 2024), is expected to be in line with the revised guidance in the Update of £4.3m. Earnings before Interest, Taxation, Depreciation and Amortisation (EBITDA) from continuing operations are expected to be approximately £10.0m on the same basis.

 

Trading in 2024 has started well with a number of new business wins already secured including assignments with existing Client Boehringer Ingelheim, expanding our involvement with the animal health arm of their business. The new remit includes activity from top-level strategy, through to activation for an exciting portfolio of brands.

 

Other new business wins across the Group since the start of the new financial year include new Client Herta UK for MISSION Agency Speed. Speed will be working closely with the UK arm of German based Herta, which provides quality chilled goods to consumers and will be focused on amplifying Herta UK's presence within trade and consumer media.  Bray Leino have also been delighted to announce a new Client mandate with global pharmaceutical company Dr. Reddy's. The new scope includes all facets of marketing from branding and packaging to event creation and delivery.

 

 

VALUE RESTORATION PLAN ("VRP")

 

The Group continues to make good progress against its recovery plan to drive significant cost saving initiatives and margin improvements and has now secured an annualised, projected £5m of profit improvements for 2024. This includes an initial £2m of annualised costs savings relating to headcount reduction in certain of the Group's business units and a further £3m of annualised non-agency cost savings and profit improvements.

 

Part of the Group's VRP also includes the selected disposals of two non-core businesses and on 5th January 2024 the Group was pleased to confirm the disposal of its 80% shareholding in Pathfindr ltd, with the initial proceeds of £1m being deployed to reduce debt. 

 

BALANCE SHEET

 

Net bank debt as at 31 December 2023 is estimated to be £15.5m. This is a considerable improvement on the previously stated guidance of £24m, provided in the Update.

 

This improvement has been driven by strong working capital control both in regard to billing and debtor days management and the active management of our creditors, including an agreed £4.3m HMRC Time To Pay arrangement phased over the first quarter of 2024.

 

The Group enters 2024 with the benefit of significantly improved headroom against its current debt facility of £29m.

 

Chief Executive of MISSION, James Clifton, commented: "Whilst 2023 has not been without significant challenges, the Board is pleased with the progress being made to restore value for shareholders through the Value Restoration Plan.

 

"Whilst there is much more to do, efficiencies are quickly being realised and we are particularly pleased to have achieved a significant reduction in net debt against our original forecasts.

 

"Trading momentum in the later part of 2023 was encouraging, with growth ahead of the market, and the recent new business wins in January give us confidence as we enter 2024."

 

ENDS

 

 

ENQUIRIES

 

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

Via Houston

 

Simon Bridges/Andrew Potts/Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

 

NOTES TO EDITORS

 

MISSION is a collective of digital marketing and communications Agencies employing over 1,000 people across 29 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

The person responsible for arranging the release of this announcement on behalf of MISSION is James Clifton.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNABRSOUAAAR
Date   Source Headline
4th Jun 20267:00 amRNSNotice of AGM and Posting of Annual Report
21st May 202611:46 amRNSDirector/PDMR Shareholding
1st May 20262:45 pmRNSHolding(s) in Company
28th Apr 202611:00 amRNSHolding(s) in Company
27th Mar 20264:50 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
20th Mar 202612:00 pmRNSNotice of Investor Presentation
18th Feb 20267:00 amRNSGrowth Share Scheme
13th Jan 20267:00 amRNSBoard Changes
13th Jan 20267:00 amRNSFull Year Trading Update
17th Oct 20257:00 amRNSDirectorate Change
10th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2025
12th Sep 20257:00 amRNSBOARD CHANGES
22nd Aug 20257:00 amRNSNOTICE OF RESULTS AND INVESTOR PRESENTATION
12th Aug 20254:22 pmRNSHolding(s) in Company
6th Aug 20256:24 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNSTrading Update
1st Jul 20257:00 amRNSMISSION Group plc appoints John Carey as new CEO
16th Jun 20251:19 pmRNSResult of AGM
16th Jun 20257:00 amRNSAGM Trading Update
11th Jun 202511:44 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 202510:16 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
10th Mar 20257:00 amRNSInvestor Presentation
17th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20258:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNS2024 Full Year Trading Update
13th Jan 20259:30 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20253:47 pmRNSHolding(s) in Company
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSShare buyback programme
2nd Jan 20257:00 amRNSDisposal and Capital Allocation Update
21st Nov 20247:00 amRNSDirectorate Change
24th Sep 20247:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2024
9th Sep 20247:00 amRNSNotice of Results
25th Jul 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.